tiprankstipranks
Trending News
More News >
Mirum Pharmaceuticals Inc (MIRM)
NASDAQ:MIRM
US Market
Advertisement

Mirum Pharmaceuticals (MIRM) Ownership - Who Owns Mirum Pharmaceuticals?

Compare
694 Followers

Mirum Pharmaceuticals (MIRM) Ownership Overview

9.02%25.74%0.39%12.64%52.22%
0.39% Other Institutional Investors
12.64% ETFs
52.22% Public Companies and
Individual Investors
The ownership structure of Mirum Pharmaceuticals (MIRM) stock is a mix of institutional, retail, and individual investors. Approximately 38.76% of the company’s stock is owned by Institutional Investors, 9.02% is owned by Insiders, and 52.22% is owned by Public Companies and Individual Investors.
The ownership structure of Mirum Pharmaceuticals (MIRM) stock is a mix of institutional, retail, and individual investors. Approximately 26.13% of the company’s stock is owned by Institutional Investors, 9.02% is owned by Insiders, and 12.64% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Aug 12, 2025
xxxxxxxxxxxxx
$526960
Jun 13, 2025
xxxxxxxxxxxxx
$155089
Jun 04, 2025
xxxxxxxxxxxxx
$377829
Mar 18, 2025
xxxxxxxxxxxxx
$24213

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2025
xxxxxxxxxxxxx
$369766
Jun 30, 2025
xxxxxxxxxxxxx
$494956
Jun 30, 2025
xxxxxxxxxxxxx
$28900125

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
3,741,287Insider7.45%254,145,626
2,561,344Institution5.10%173,992,098
2,185,584Institution4.35%148,466,721
2,050,409Institution4.08%139,284,283
1,880,346Institution3.74%127,731,904
1,854,002Institution3.69%125,942,356
757,244Institution1.51%51,439,585
683,379Institution1.36%46,421,935
682,393Institution1.36%46,354,956
666,587Institution1.33%45,281,255

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
2,561,344Institution5.10%173,992,098
2,050,409Institution4.08%139,284,283
1,880,346Institution3.74%127,731,904
757,244Institution1.51%51,439,585
682,393Institution1.36%46,354,956
666,587Institution1.33%45,281,255
433,383Institution0.86%29,439,707
410,379Institution0.82%27,877,045
329,204Institution0.66%22,362,828
316,547Institution0.63%21,503,038

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,339,443Institution2.67%69,222,414
1,039,794Institution2.07%70,633,206
471,662Institution0.94%30,577,847
446,401Institution0.89%23,070,004
382,274Institution0.76%25,967,873
246,890Institution0.49%16,771,238
207,110Institution0.41%10,703,445
196,411Institution0.39%12,733,325
128,710Institution0.26%8,344,269
128,710Institution0.26%8,344,269

FAQ

Who Owns Mirum Pharmaceuticals Inc (MIRM)?
According to the latest TipRanks data, approximately 0.39% of the company's stock is held by institutional investors, 9.02% is held by insiders, and 52.22% is held by retail investors.
    What percentage of Mirum Pharmaceuticals Inc (MIRM) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.39% of Mirum Pharmaceuticals Inc (MIRM) stock is held by institutional investors.
      What percentage of Mirum Pharmaceuticals Inc (MIRM) stock is held by retail investors?
      According to the latest TipRanks data, approximately 52.22% of Mirum Pharmaceuticals Inc (MIRM) stock is held by retail investors.
        Who owns the most shares of Mirum Pharmaceuticals Inc (MIRM)?
        Patrick Heron owns the most shares of Mirum Pharmaceuticals Inc (MIRM).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis